Kamyar Kalantar-Zadeh M.D. to Stroke
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Stroke.
Connection Strength
5.298
-
Constipation and risk of death and cardiovascular events. Atherosclerosis. 2019 02; 281:114-120.
Score: 0.586
-
Association of Systolic Blood Pressure Variability With Mortality, Coronary?Heart?Disease, Stroke, and?Renal?Disease. J Am Coll Cardiol. 2016 09 27; 68(13):1375-1386.
Score: 0.502
-
Racial Differences in Association of Serum Calcium with Mortality and Incident Cardio- and Cerebrovascular Events. J Clin Endocrinol Metab. 2016 12; 101(12):4851-4859.
Score: 0.500
-
Age, Race and Cardiovascular Outcomes in African American Veterans. Ethn Dis. 2016 07 21; 26(3):305-14.
Score: 0.495
-
Age and Outcomes Associated with BP in Patients with Incident CKD. Clin J Am Soc Nephrol. 2016 05 06; 11(5):821-831.
Score: 0.487
-
Response to Letter Regarding Article, "Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans". Circulation. 2016 Mar 22; 133(12):e453.
Score: 0.484
-
Association of incident restless legs syndrome with outcomes in a large cohort of US veterans. J Sleep Res. 2016 Feb; 25(1):47-56.
Score: 0.479
-
Impact of Non-Adherence on Renal and Cardiovascular Outcomes in US Veterans. Am J Nephrol. 2015; 42(2):151-7.
Score: 0.468
-
Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans. Circulation. 2015 Oct 20; 132(16):1538-48.
Score: 0.467
-
Association of incident obstructive sleep apnoea with outcomes in a large cohort of US veterans. Thorax. 2015 Sep; 70(9):888-95.
Score: 0.458
-
Warfarin Use, Stroke, and Bleeding Risk among Pre-Existing Atrial Fibrillation US Veterans Transitioning to Dialysis. Nephron. 2022; 146(4):360-368.
Score: 0.182
-
Darbepoetin alfa and chronic kidney disease. N Engl J Med. 2010 Feb 18; 362(7):654; author reply 655.
Score: 0.079
-
Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes: A Randomized Clinical Trial. JAMA. 2020 04 28; 323(16):1565-1573.
Score: 0.040
-
Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial. Am Heart J. 2019 11; 217:72-83.
Score: 0.038
-
Warfarin Use and Increased Mortality in End-Stage Renal Disease. Am J Nephrol. 2017; 46(4):249-256.
Score: 0.034